RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Inventories

Edwards Lifesciences CorpEW

Market cap
$49.7B
P/E ratio
SummaryFinancials
Period EndInventories (Million USD)YoY (%)
Dec 31, 20241,087-6.98%
Dec 31, 20231,168+33.43%
Dec 31, 2022876+20.48%
Dec 31, 2021727-9.42%
Dec 31, 2020802+25.18%
Dec 31, 2019641+5.58%
Dec 31, 2018607+9.39%
Dec 31, 2017555+39.91%
Dec 31, 2016397+16.68%
Dec 31, 2015340+14.52%
Dec 31, 2014297-3.92%
Dec 31, 2013309+9.93%
Dec 31, 2012281+7.54%
Dec 31, 2011261+28.34%
Dec 31, 2010204

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)